Merit Medical Systems, Inc. (MMSI)

Merit Medical Systems, Inc.'s Q·Score is 7.6/10 (Bullish), reflecting its current fundamentals, analyst data, and valuation metrics. Consensus analyst target of $90.64 is 46% above current price. This is an informational data summary only and does not constitute financial advice. Always do your own research before making any investment decision.

The consensus price target for MMSI is $90.64, based on ratings from 11 Wall Street analysts. This is 46.2% above the current price of $62.01. Price targets are forward-looking estimates and not guarantees of future performance.

Merit Medical Systems, Inc. (MMSI) scores favorably on valuation metrics relative to sector peers and analyst targets. Its forward P/E ratio stands at 14.1×. The consensus analyst price target of $90.64 is 46% above the current price.

Merit Medical Systems, Inc.'s next earnings report is expected on approximately July 30, 2026.

Merit Medical Systems, Inc. has a net profit margin of 9.0%, which is positive but relatively thin. Its gross margin stands at 48.7%, reflecting a more cost-intensive business model.

Merit Medical Systems, Inc. is reporting modest revenue growth of 7.5%. Earnings are also growing at 38.8%, indicating improving profitability.

Merit Medical Systems, Inc. has a debt-to-equity ratio of 0.51×, reflecting a moderate debt level, which is manageable for most profitable companies. Its current ratio is 5.08×, indicating comfortable short-term liquidity.